Showing 1 - 9 of 9 trials – Showing only trials currently accepting patients

• Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

  Stanford is currently accepting patients for this trial.

• Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

  Stanford is currently accepting patients for this trial.

• Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

  Stanford is currently accepting patients for this trial.

• Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

  Stanford is currently accepting patients for this trial.

• Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

  Stanford is currently accepting patients for this trial.

• Nanatinostat Plus Valganciclovir in Patients With Advanced EBV+ Solid Tumors, and in Combination With Pembrolizumab in EBV+ RM-NPC

  Stanford is currently accepting patients for this trial.

• T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

  Stanford is currently accepting patients for this trial.

• Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)

  Stanford is currently accepting patients for this trial.

• Study of Magrolimab Combination Therapy in Participants With Head and Neck Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.